These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3380229)

  • 21. Effect of dialysis on circulating Na,K ATPase inhibitor in uremic patients.
    Stokes GS; Norris LA; Marwood JF; Johnston H; Caterson RJ
    Nephron; 1990; 54(2):127-33. PubMed ID: 2156180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AQP1 in red blood cells of uremic patients during hemodialytic treatment.
    Buemi M; Floccari F; Di Pasquale G; Cutroneo G; Sturiale A; Aloisi C; Ruello A; Romeo A; Favaloro A; Corica F; Frisina N; Anastasi G
    Nephron; 2002 Dec; 92(4):846-52. PubMed ID: 12399631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of circulating sodium-pump inhibitory activity in uraemia and essential hypertension.
    Stokes GS; Willcocks D; Monaghan J; Boutagy J; Marwood JF
    J Hypertens Suppl; 1986 Dec; 4(6):S376-8. PubMed ID: 2441015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Trans-membrane cationic flow and hemodialysis].
    Sechi LA; Orecchioni C; Melis A; Pala A; Tedde R
    Boll Soc Ital Biol Sper; 1990 Oct; 66(10):1001-8. PubMed ID: 1710902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The mechanism of Na+--K+ pump dysfunction in the erythrocytes of patients with glomerulonephritis and kidney failure].
    Ponomarenko ED; Lazovskis IR; Pletneva TP; Maslova MN
    Ter Arkh; 1991; 63(5):105-9. PubMed ID: 1653466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium transport and red cell deformability.
    Wambach G; Overhoff U; Hossmann V
    Klin Wochenschr; 1985; 63 Suppl 3():35-7. PubMed ID: 2582181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium and potassium concentrations of red blood cells and plasma in children with nephrotic syndrome, uraemia and pyelonephritis.
    Toldi Z; Turi S
    Acta Paediatr Hung; 1986; 27(4):283-8. PubMed ID: 3593578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients.
    Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
    J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P; Ferrant A; Daelemans R; Coolen L; Goossens W; Lins RL; Couttenye M; De Broe ME; Boogaerts MA
    Nephron; 1993; 65(2):288-93. PubMed ID: 8247195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uremic plasma as cause of metabolic changes in red blood cells].
    Eggert W; Schmidt G; Devaux S
    Z Urol Nephrol; 1981 Feb; 74(2):141-7. PubMed ID: 7223096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroelectrolytic equilibrium change in dialysis.
    Redaelli B
    J Nephrol; 2001; 14 Suppl 4():S7-11. PubMed ID: 11798149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Na+-K+ pump in chronic renal failure.
    Kaji D; Thomas K
    Am J Physiol; 1987 May; 252(5 Pt 2):F785-93. PubMed ID: 2437805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of renal failure and renal replacement therapy on the activity of erythrocyte sodium-proton exchanger].
    Kwiatkowska E
    Ann Acad Med Stetin; 2004; 50(1):25-33. PubMed ID: 16871741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the endogenous Na+-pump inhibitor in essential hypertension and blood volume expansion.
    Devynck MA; Pernollet MG; Deray G; Wauquier I; Delva P; Rieu M; Henning G; Cloix JF; Crabos M; Baudouin-Legros M
    J Hypertens Suppl; 1984 Dec; 2(3):S453-5. PubMed ID: 6100747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system.
    Manlucu J; Gallo K; Heidenheim PA; Lindsay RM
    Am J Kidney Dis; 2010 Jul; 56(1):69-76. PubMed ID: 20303632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrocyte Na-stimulated Mg transport in uremic patients undergoing CAPD.
    Quarello F; Guarena C; Boero R; Bonello F; Belardi P; Maffei S; Beltrame G; Reinero G; Piccoli G
    Adv Perit Dial; 1990; 6():207-10. PubMed ID: 1982810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
    Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
    Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
    Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.